The genomics industry is about commercializing the genome. We are witnessing a modern-day gold rush to discover and patent genes, gene variation, gene function, and corresponding gene proteins. Genomics is a true platform technology genomic discoveries can be leveraged across many revenue-generating opportunities. The general categories of future genomic product revenues are listed in Exhibit 1 and are described below. Bioinformatics Database subscription Protein drugs Drug targets Genome sequence.
Genome sequence is simply an ordered map of the DNA molecules in a given organism.
It is the ultimate description of the genome, as the periodic table of the elements is for chemistry or as an alphabet is for a language. The commercial value of the sequence will be realized as additional layers of genomic information are added to it. For example, proprietary genome sequences of other species may be added to commercial databases that facilitate comparative experiments to discover gene function. These databases will become important repositories of information for biotechnology and pharmaceutical companies as they pursue downstream commercialization strategies. Gene discovery and function.